Furthermore, TBK1 activity is selectively essential for the survival of cancer cells with mutant KRAS, identified in a systematic synthetic lethal RNAi screening in NCI-H23 cells, a lung cancer cell line expressing mutant KRAS (Barbie et al., 2009). Here, KRAS is linked to cancer.